Curcumin-loaded nanocomplexes alleviate the progression of fluke-related cholangiocarcinoma in hamsters

[1]  B. Razavi,et al.  A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents , 2021, Phytotherapy research : PTR.

[2]  T. Matsuura,et al.  Spontaneous cholangiofibrosis adjacent to a dilated common bile duct with intestinal metaplasia in a Royal College of Surgeons rat , 2021, Journal of toxicologic pathology.

[3]  C. Pairojkul,et al.  Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters , 2021, Toxicology reports.

[4]  C. Pairojkul,et al.  Solid dispersion improves release of curcumin from nanoparticles: Potential benefit for intestinal absorption , 2021 .

[5]  C. Pairojkul,et al.  Fluke-Associated Cholangiocarcinoma: A Regional Epidemic , 2021 .

[6]  A. Daneshkhah,et al.  Clinical effects of curcumin in enhancing cancer therapy: A systematic review , 2020, BMC Cancer.

[7]  G. Michalopoulos,et al.  Liver regeneration: biological and pathological mechanisms and implications , 2020, Nature Reviews Gastroenterology & Hepatology.

[8]  G. Gores,et al.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.

[9]  Shu-sen Zheng,et al.  CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype , 2020, Journal of Cancer.

[10]  P. Bannasch.  Letter to the Editor Regarding “Cholangiofibrosis and Related Cholangiocellular Neoplasms in Rodents” , 2019, Toxicologic pathology.

[11]  R. Ghidoni,et al.  Dietary Curcumin: Correlation between Bioavailability and Health Potential , 2019, Nutrients.

[12]  P. Devarajan,et al.  Enhancing Curcumin Oral Bioavailability Through Nanoformulations , 2019, European Journal of Drug Metabolism and Pharmacokinetics.

[13]  S. Jafari,et al.  Gum-based nanocarriers for the protection and delivery of food bioactive compounds. , 2019, Advances in colloid and interface science.

[14]  Ke Chen,et al.  Spontaneous Cholangiofibrosis in a Wistar Rat , 2019, Toxicologic pathology.

[15]  G. Gores,et al.  Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances , 2019, Hepatology.

[16]  G. Zhai,et al.  Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks , 2019, Journal of drug targeting.

[17]  S. Glaser,et al.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances , 2018, Hepatology.

[18]  Eyaldeva C Vijayakumar,et al.  High Mobility Group Box-1 (HMGB1): A potential target in therapeutics. , 2019, Current drug targets.

[19]  T. Boonmars,et al.  Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer , 2018, PloS one.

[20]  S. Jafari,et al.  Application of different nanocarriers for encapsulation of curcumin , 2018, Critical reviews in food science and nutrition.

[21]  K. Srikaeo,et al.  Effects of gums on physical properties, microstructure and starch digestibility of dried-natural fermented rice noodles. , 2018, International journal of biological macromolecules.

[22]  W. Ridtitid,et al.  Liver Fluke-Associated Biliary Tract Cancer , 2017, Gut and liver.

[23]  P. Brindley,et al.  Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma. , 2018, Advances in parasitology.

[24]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[25]  S. Forbes,et al.  Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma , 2017, npj Regenerative Medicine.

[26]  M. Baker.  Deceptive curcumin offers cautionary tale for chemists , 2017, Nature.

[27]  P. Brindley,et al.  Parasite Infection, Carcinogenesis and Human Malignancy , 2016, EBioMedicine.

[28]  Francisco J B Veiga,et al.  Gums' based delivery systems: Review on cashew gum and its derivatives. , 2016, Carbohydrate polymers.

[29]  Yong-lu Wang,et al.  Choleretic Activity of Turmeric and its Active Ingredients. , 2016, Journal of food science.

[30]  Xin Liu,et al.  Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge , 2016, Molecular medicine reports.

[31]  G. Zhai,et al.  Oral bioavailability of curcumin: problems and advancements , 2016, Journal of drug targeting.

[32]  C. Pairojkul,et al.  Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[33]  Duxin Sun,et al.  Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy , 2016, The AAPS Journal.

[34]  Jingru Zhang,et al.  Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells , 2014, Journal of Molecular Medicine.

[35]  I. Beis,et al.  Curcumin acts as a pro-oxidant inducing apoptosis via JNKs in the isolated perfused Rana ridibunda heart. , 2013, Journal of experimental zoology. Part A, Ecological genetics and physiology.

[36]  I. Wierstra,et al.  FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. , 2013, Advances in cancer research.

[37]  Q. Gong,et al.  Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice. , 2012, European journal of pharmacology.

[38]  H. Bartsch,et al.  Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. , 2012, Parasitology international.

[39]  K. Leelawat,et al.  Prognostic relevance of circulating CK19 mRNA in advanced malignant biliary tract diseases. , 2012, World journal of gastroenterology.

[40]  B. Aggarwal,et al.  Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. , 2011, Carcinogenesis.

[41]  B. Aggarwal,et al.  Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation‐mediated molecular events related to multistep carcinogenesis , 2011, International journal of cancer.

[42]  Khajeelak Chiablaem,et al.  Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[43]  J. Ward,et al.  Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System , 2010, Toxicologic pathology.

[44]  C. Pairojkul,et al.  Involvement of MMP‐9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1‐dependent DNA damage in a hamster model , 2010, International journal of cancer.

[45]  A. Shehzad,et al.  Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials , 2010, Archiv der Pharmazie.

[46]  Y. Hiraku,et al.  Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. , 2010, European journal of pharmacology.

[47]  Hai-rim Shin,et al.  Epidemiology of cholangiocarcinoma: An update focusing on risk factors , 2010, Cancer science.

[48]  Y. Hiraku,et al.  Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. , 2009, Molecular nutrition & food research.

[49]  T. Boonmars,et al.  Turmeric reduces inflammatory cells in hamster opisthorchiasis , 2009, Parasitology Research.

[50]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[51]  Y. Hiraku,et al.  Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis , 2006, Biological chemistry.

[52]  C. Pairojkul,et al.  Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. , 2005, World journal of gastroenterology.

[53]  Xavier Matias-Guiu,et al.  NF-kB in development and progression of human cancer , 2005, Virchows Archiv.

[54]  P. Pisani,et al.  Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.

[55]  B. Gullberg,et al.  Estimation of liver tumor volume using different formulas—An experimental study in rats , 2004, Journal of Cancer Research and Clinical Oncology.

[56]  K. Imaida,et al.  A Review of Nomenclature and Diagnostic Criteria for Proliferative Lesions in the Liver of Rats by a Working Group of the Japanese Society of Toxicologic Pathology , 2003 .

[57]  A. Lelo,et al.  Effect of different curcumin dosages on human gall bladder. , 2002, Asia Pacific journal of clinical nutrition.

[58]  L. Caplan,et al.  Exposure to N-nitroso compounds in a population of high liver cancer regions in Thailand: volatile nitrosamine (VNA) levels in Thai food. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[59]  S. Sell,et al.  Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. , 1997, Journal of hepatology.

[60]  C. Pairojkul,et al.  Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver. , 1994, Cancer letters.

[61]  S. E. West,et al.  Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon , 1977, Applied and environmental microbiology.